Although we demonstrated that blocking CCR7 signal on tumor cells enhanced the sorafenib sensitivity of HCC, which was mediated by inhibiting the EMT process and leaded to the tumor suppression, the mechanisms behind these changes remain unclear. This evidence concerns the gene CCR7 and neoplasm.